EAGLE MATERIALS INC (EXP): debt financing — Eagle Materials issues $750M 5.000% Senior Notes due 2036, repays revolver

EAGLE MATERIALS INC

$750M aggregate principal of 5.000% Senior Notes due March 15, 2036 issued under a Third Supplemental Indenture.
Net proceeds of ~$734.9M after underwriting discounts; used to repay revolver borrowings and for general corporate purposes.
Interest payable semi-annually on March 15 and September 15, beginning March 15, 2026.
Notes are senior unsecured, rank equally with existing unsubordinated debt; redeemable at par after Dec 15, 2035.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

EAGLE MATERIALS INC incurred senior notes of $750.0 million with The Bank of New York Mellon Trust Company, N.A. at 5.000% maturing March 15, 2036.

Instrument: senior notes
Principal: $750.0 million
Counterparty: The Bank of New York Mellon Trust Company, N.A.
Rate: 5.000%
Maturity: March 15, 2036
Event: incurrence

Exact text from the filing

On November 6, 2025, Eagle Materials Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters identified on Schedule 1 thereto (the “Underwriters”), with respect to the offer and sale in an underwritten public offering (the “Offering”) by the Company of $750.0 million in aggregate principal amount of its 5.000% Senior Notes due 2036 (the “Notes”).

View on SEC.gov

102 debt financings filed in the last 30 days. Browse all debt financings →

EAGLE MATERIALS INC filing history →

Source: SEC EDGAR

accession 0001193125-25-280206

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.